Data Quality Platform
Modular ultrasound platform with organ and disease-specific AI solutions
Platform · EmbeddedCompany source
Company profile
About ContextVision
ContextVision is a publicly traded medical technology software company that has established itself as a global leader in image enhancement and artificial intelligence for medical imaging. The company specializes in developing advanced image analysis solutions that are integrated into ultrasound, X-ray, and MRI equipment manufactured by leading OEMs worldwide. With over 400,000 systems installed globally, ContextVision's technology enhances image quality to enable faster and more reliable diagnostics. The company offers versatile and scalable post-processing software solutions that are customized for each medical imaging system, situation, and clinical need. Leveraging four decades of imaging expertise, ContextVision has recently expanded beyond traditional image quality enhancement to develop a modular ultrasound platform called Data Quality. This platform adds organ and disease-specific solutions and supports biomarker research, with an initial focus on metabolic dysfunction-associated steatotic liver disease (MASLD). ContextVision partners with renowned medical imaging equipment manufacturers and leading research institutions to advance diagnostic capabilities. The company's ultimate goal is to collaboratively transform the future of healthcare by providing AI-driven solutions that deliver meaningful diagnostic insights directly at the point-of-care. Their technology combines deep expertise in medical imaging with cutting-edge artificial intelligence to improve clinical clarity, diagnostic confidence, and workflow efficiency for healthcare providers worldwide.
Company description ContextVision official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at ContextVision?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Breast cancer
- Liver steatosis
- MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease)
- Thyroid nodule screening
Who it serves
- Medical imaging equipment manufacturers (OEMs)
- MRI equipment manufacturers
- Ultrasound equipment manufacturers
- X-ray equipment manufacturers
Deployment & integration
Embedded deployment with recorded integration context.
Geographic context
MarketsCanada · Global · Norway · Sweden · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launched Data Quality platform expanding beyond image enhancement to organ-specific solutions and biomarker research (2025); Strategic partnership with BeamWorks for AI-powered ultrasound diagnostics; Partnership with AMRA Medical for MASLD diagnostics combining MRI and ultrasound; Research partnerships with University of Waterloo and InPhase Solutions (2025); Partnership with University of Washington for liver disease diagnosis
Partnerships
Recorded partners
- AMRA Medical
- BeamWorks
- InPhase Solutions AS
- University of Washington / UW Medicine
- University of Waterloo LITMUS Lab
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Image Quality Solutions - MRI
AI-powered image enhancement software for MRI systems
Software · EmbeddedCompany source
Image Quality Solutions - Ultrasound
AI-powered image enhancement software for ultrasound systems
Software · EmbeddedCompany source
Image Quality Solutions - X-ray
AI-powered image enhancement software for X-ray systems
Software · EmbeddedCompany source
Veterinary Image Enhancement
Image enhancement solutions for veterinary medical imaging
Software · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Evaluation of A Computer-Aided Detection Software for Prostate Cancer Prediction: Excellent Diagnostic Accuracy Independent of Preanalytical Factors.Laboratory investigation; a journal of technical methods and pathology · Dec 1, 2023
Modular deep reinforcement learning from reward and punishment for robot navigation.Neural networks : the official journal of the International Neural Network Society · Mar 1, 2021
Proactive Construction of an Annotated Imaging Database for Artificial Intelligence Training.Journal of digital imaging · Feb 1, 2021
Predicting breast tumor proliferation from whole-slide images: The TUPAC16 challenge.Medical image analysis · May 1, 2019
Clinical validation
Clinical-trial records
Development of a Quantifiable Ultrasound Biomarker for Hepatic SteatosisNCT07270601 · Sponsor · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Faster diagnostics
Enhanced image quality leading to faster and more reliable diagnostics for patients worldwide
Improved diagnostic confidence
Next-gen image enhancement that elevates clinical clarity and diagnostic confidence
Workflow efficiency
Enhanced workflow efficiency through improved image quality
Global OEM Partners
Image enhancement across ultrasound, X-ray and MRI systems
Installed in over 400,000 systems worldwide
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from ContextVision
Recent articles published on ContextVision's official website.
ContextVision Q1 Interim report 2026
Read on ContextVisionContextVision AB: Q2 interim report 2025 – Customers pressured by trade uncertainty – We continue to invest to build tomorrow’s solutions
Read on ContextVisionContextVision publishes Webcast for the Q2 report 2025
Read on ContextVisionContextVision Q3 Interim Report 2025
Read on ContextVisionContextVision Q2 Interim report 2026
Read on ContextVision07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.